But new data from a recent clinical trial suggests that a previously discontinued experimental drug, called gantenerumab, ...
Alzheimer's Disease (AD) is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like ...
A new study from Auburn University provides new insights into neuronal connections, offering hope for the treatment of ...
The brain's cholesterol regulation and metabolism mechanisms may make some neurons more vulnerable to damage in the early ...
The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...
For the first time, scientists from the University of Delaware College of Health Sciences and the National Institute on Aging ...
Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.
News Medical on MSN12d
CD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic targetA comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...
New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...
ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback